Metraipolis › archive › dc_ebd42a538bd1

Evaluation of CCL21 role in post-knee injury inflammation and early cartilage degeneration — Europe PMC PMID:33651836

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33651836
DOI
10.1371/journal.pone.0247913
License (as archived)
CC0-1.0
Archived
2026-11-05T17:14:15.592Z
SHA-256 of the archived text
230d8a024da38ebd74ea83dccd02b02bc0ddb986c4ba9b2eec079b5e6d63c061
Stable URL of this page
https://metraipolis.com/documento/dc_ebd42a538bd1

How to cite

Evaluation of CCL21 role in post-knee injury inflammation and early cartilage degeneration — Europe PMC PMID:33651836 — Europe PMC (en), https://europepmc.org/article/MED/33651836 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ebd42a538bd1 (Metraipolis archive dc_ebd42a538bd1, sha256 230d8a024da38ebd74ea83dccd02b02bc0ddb986c4ba9b2eec079b5e6d63c061)
BibTeX
@misc{dcebd42a538bd1,
  title = {Evaluation of CCL21 role in post-knee injury inflammation and early cartilage degeneration — Europe PMC PMID:33651836},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33651836},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ebd42a538bd1; sha256 230d8a024da38ebd74ea83dccd02b02bc0ddb986c4ba9b2eec079b5e6d63c061},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33651836. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The expression of some chemokines and chemokine receptors is induced during the development of post-traumatic osteoarthritis (PTOA), but their involvement in the pathogenesis of the disease is unclear. The goal of this study was to test whether CCL21 and CXCL13 play a role in PTOA development. For this purpose, we evaluated the expression profiles of the chemokines Ccl21 and Cxcl13, matrix metalloproteinase enzymes Mmp3 and Mmp13, and inflammatory cell markers in response to partial medial meniscectomy and destabilization (MMD). We then assessed the effect of local administration of CCL21 neutralizing antibody on PTOA development and post-knee injury inflammation. The mRNA expression of both Ccl21 and Cxcl13 was induced early post-surgery, but only Ccl21 mRNA levels remained elevated 4 weeks post-surgery in rat MMD-operated knees compared to controls. This suggests that while both CXCL13 and CCL21 are involved in post-surgery inflammation, CCL21 is necessary for development of PTOA. A significant increase in the mRNA levels of Cd4, Cd8 and Cd20 was observed during the first 3 days post-surgery. Significantly, treatment with CCL21 antibody reduced post-surgical inflammation that was accompanied by a reduction in the expression of Mmp3 and Mmp13 and post-MMD cartilage degradation. Our findings are consistent with a role for CCL21 in mediating changes in early inflammation and subsequent cartilage degeneration in response to knee injury. Our results suggest that targeting CCL21 signaling pathways may yield new therapeutic approaches effective in delaying or preventing PTOA development following injury.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-03-02).
Identificativi: PMID 33651836 · PMCID PMC7924772 · DOI 10.1371/journal.pone.0247913.
Pagina: https://europepmc.org/article/MED/33651836 — https://doi.org/10.1371/journal.pone.0247913. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T17:03:07.569Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.